Prospective Validation Study for the Proprietary Rectal and Anal Cancer Protein Expression Assays

NCT02407561 · clinicaltrials.gov ↗

TERMINATED

Status

3

Enrollment

INDUSTRY

Sponsor class

Stopped Futility - unable to secure sites and samples for participation

Conditions

Rectal Adenocarcinoma
Anal Adenocarcinoma
Anal Squamous Cell Carcinoma

Sponsor

Castle Biosciences Incorporated